Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Name / Ticker | Price | Zen Rating |
---|---|---|
$13.95 | A | |
$41.34 | A | |
$12.40 | A |